Super-Strength Cannabis Prescribed for Mental Health Woes

Thousands of Britons are now receiving super-strength cannabis prescriptions from private clinics for mental health conditions like anxiety and depression. This practice occurs despite strong warnings from the NHS regarding the increased risk of severe mental health problems associated with marijuana use. Private clinics are prescribing nearly all of the medical cannabis in Britain, exploiting loopholes that allow for the distribution of unlicensed products.

The volume of prescribed cannabis has seen a substantial rise, with nearly ten tons dispensed in 2024, a significant increase from 2023. Experts, including Professor Sir Robin Murray, have voiced serious concerns, calling the situation 'outrageous' and highlighting the potential for increased dependence and psychiatric side-effects. He likens the practice to using alcohol for depression, noting short-term relief but long-term worsening.

This trend has led to fears that a pseudo-recreational market is emerging due to lax regulations. While licensed medical cannabis is available for specific conditions like severe epilepsy on the NHS, private clinics can prescribe unlicensed products. The government has stated that regulators are expected to crack down on private providers who do not offer proper clinical care.